Literature DB >> 24621097

Prognostic relevance of histological variants in nonspecific interstitial pneumonia.

Marianne Kambouchner1, Pierre Levy, Andrew G Nicholson, Kirsten Schubel, Eline Magois, Séverine Feuillet, Dominique Valeyre, Jean-François Bernaudin, Hilario Nunes.   

Abstract

AIMS: Although histological non-specific interstitial pneumonia (NSIP) is concisely defined, overlap with other patterns is described. While most frequently idiopathic, NSIP is seen in various clinical contexts such as connective tissue diseases (CTDs) and chronic hypersensitivity pneumonitis (cHP). This study was designed to determine if NSIP could be separated into subgroups based on minor histological features and to correlate these subgroups with clinical associations and survival. METHODS AND
RESULTS: One hundred and thirty-six patients with biopsy-proven NSIP were included [clinical diagnosis: CTDs (23%), cHP (12%), idiopathic (65%)]. In addition to the agreed NSIP criteria, seven subgroups were identified: essential NSIP and six overlap subgroups according to superimposed minor histological features. Interobserver concordance resulted in the following consensus: essential NSIP (36%), usual interstitial pneumonia (UIP) overlap (26%), cHP overlap (10%), organizing pneumonia (OP) overlap (6%), organizing diffuse alveolar damage (DAD) overlap (10%), desquamative interstitial pneumonia overlap (7%) and lymphoid interstitial pneumonia overlap (2%). OP overlap was associated with CTDs (P = 0.04) and cHP overlap with a cHP clinical diagnosis (P = 0.02). Survival was different between subgroups (P = 0.0002). Organizing DAD overlap exhibited poorer survival at 5 years (32%), followed by UIP overlap (57%). Independent predictors of mortality were organizing DAD overlap (HR = 4.99, 95% CI = 2.15-11.58, P = 0.0002), UIP overlap (HR = 2.11, 95% CI = 1.12-3.99, P = 0.02) and a clinical diagnosis of cHP (HR = 2.17, 95% CI = 1.05-4.47, P = 0.035).
CONCLUSIONS: Non-specific interstitial pneumonia subdivision into pathological subgroups is clinically relevant from a prognostic and causal perspective.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  aetiology; non-specific interstitial pneumonia; pathology; survival

Mesh:

Year:  2014        PMID: 24621097     DOI: 10.1111/his.12415

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  [Interstitial processes of the lungs in childhood].

Authors:  H Popper
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

2.  Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease.

Authors:  Julie Obert; Olivia Freynet; Hilario Nunes; Pierre-Yves Brillet; Makoto Miyara; Robin Dhote; Dominique Valeyre; Jean-Marc Naccache
Journal:  Rheumatol Int       Date:  2016-10-08       Impact factor: 2.631

3.  Central paradiaphragmatic middle lobe involvement in nonspecific interstitial pneumonia.

Authors:  Joanna G Escalon; Alan C Legasto; Dennis Toy; James F Gruden
Journal:  Eur Radiol       Date:  2021-02-23       Impact factor: 5.315

Review 4.  Nonspecific interstitial pneumonia overlaps organizing pneumonia in lung-dominant connective tissue disease.

Authors:  Xue-Ren Li; Shou-Chun Peng; Lu-Qing Wei
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 5.  Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings.

Authors:  Tae Iwasawa; Tamiko Takemura; Takashi Ogura
Journal:  Jpn J Radiol       Date:  2017-12-15       Impact factor: 2.374

Review 6.  Pathology of Idiopathic Interstitial Pneumonias.

Authors:  Mikiko Hashisako; Junya Fukuoka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-02-29

7.  Identification of a discriminative metabolomic fingerprint of potential clinical relevance in saliva of patients with periodontitis using 1H nuclear magnetic resonance (NMR) spectroscopy.

Authors:  Matthias Rzeznik; Mohamed Nawfal Triba; Pierre Levy; Sébastien Jungo; Eliot Botosoa; Boris Duchemann; Laurence Le Moyec; Jean-François Bernaudin; Philippe Savarin; Dominique Guez
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

8.  Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China.

Authors:  Yan Li; Junhua Wu; Sihua Wang; Xiang Li; Junjie Zhou; Bo Huang; Danju Luo; Qin Cao; Yajun Chen; Shuo Chen; Lin Ma; Li Peng; Huaxiong Pan; William D Travis; Xiu Nie
Journal:  Histopathology       Date:  2020-11-11       Impact factor: 5.087

Review 9.  Interstitial lung disease pathology in systemic sclerosis.

Authors:  Kristine E Konopka; Jeffrey L Myers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-17       Impact factor: 5.346

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.